“A Modest Proposal for Financing Postmarketing Drug Safety Studies by Augmenting FDA User Fees”
Publication information:
Carpenter D. “A Modest Proposal for Financing Postmarketing Drug Safety Studies by Augmenting FDA User Fees” . Health Affairs – Web Exclusive . 2005;W5 (469).